Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.38 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.37 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28587764 | 0.83 | ALDH1A1 (0.41) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL6002883 | 0.83 | CES2 (0.41) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL3157322 | 0.81 | GAA (0.41) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL29524083 | 0.81 | GAA (0.41) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL4199099 | 0.81 | CES2 (0.40) | ALDH1A1CES2CES1KMT2AMEN1 | |
| Bicarbonate SCHEMBL29118429 | 0.80 | ALDH1A1 (0.46) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL465872 | 0.78 | POLB (0.40) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL4021117 | 0.77 | ALDH1A1 (0.43) | ALDH1A1CES2CES1KMT2AMEN1 | |
| SCHEMBL1820107 | 0.77 | POLB (0.50) | ALDH1A1CES2CES1POLBTSHR | |
| SCHEMBL30927812 | 0.77 | ALDH1A1 (0.52) | ALDH1A1POLBTSHRTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12281104-B2 | Process for the production of ethyl 3-amino-1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]pyrazole-4-carboxylate through chiral separation of a racemic mixture | INTERVET INC. (US) | 2025-04-22 | — | — | US | disclosed |
| US-20220204483-A1 | Process for the Production of Ethyl 3-Amino-1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]pyrazole-4-Carboxylate Through Chiral Separation of a Racemic Mixture | INTERVET INC. (US) | 2022-06-30 | — | — | US | disclosed |
| EP-3991835-A1 | TRIGLYCERIDE ANALYSIS METHOD, OIL AND FAT SORTING METHOD, AND TRIGLYCERIDE PRODUCTION METHOD | The Nisshin OilliO Group, Ltd. (JP) | 2022-05-04 | — | — | EP | disclosed |
| WO-2019194127-A1 | METHOD FOR ANALYZING TRIGLYCERIDE, METHOD FOR SEPARATING OIL AND FAT, AND METHOD FOR MANUFACTURING TRIGLYCERIDE | 日清オイリオグループ株式会社 | 2019-10-10 | — | — | WO | disclosed |
| US-9149791-B2 | Water-soluble carbohydrate polyethers | TRGel, LLC (US) | 2015-10-06 | — | — | US | disclosed |
| US-8642502-B2 | Reversible gel-forming compositions for controlled delivery of bioactive substances | TRGel, LLC (US) | 2014-02-04 | — | — | US | disclosed |
| US-20120087891-A1 | Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances | GORKOVENKO ALEXANDER A (US) | 2012-04-12 | — | — | US | disclosed |
| US-20120046435-A1 | Water-Soluble Carbohydrate Polyethers | GORKOVENKO ALEXANDER A (US) | 2012-02-23 | — | — | US | disclosed |
| US-7994092-B2 | Carbohydrate polyethers for chromatographic media | TRGel, LLC (US) | 2011-08-09 | — | — | US | disclosed |
| US-20090233791-A1 | Carbohydrate Polyethers for Chromatographic Media | GORKOVENKO ALEXANDER A | 2009-09-17 | — | — | US | disclosed |
| US-20090008329-A1 | Separating agent for enantiomeric isomers | DAICEL CHEMICAL INDUSTRIES, LTD. | 2009-01-08 | — | — | US | disclosed |
| US-5489387-A | Separation agent comprising acyl- or carbamoyl-substituted polysaccharide | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1996-02-06 | — | — | US | disclosed |
| US-5415780-A | Separation agent comprising acyl- or carbamoyl-substituted polysaccharide | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1995-05-16 | — | — | US | disclosed |
| US-5368737-A | Resolution | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5229002-A | Separation of optical isomers, cellulose esterified with phenylazobenzoic acid | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1993-07-20 | — | — | US | disclosed |
| US-5137638-A | Mixture of orticla isomers; cellulose tricinnamate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1992-08-11 | — | — | US | disclosed |
| US-5075009-A | Optical resolution of racemic mixtures using a cellulose tris-4-biphenyl carboxylate | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-12-24 | — | — | US | disclosed |
| US-5017290-A | Chromatography | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1991-05-21 | — | — | US | disclosed |
| US-4966694-A | CELLULOSE TRI-BETA-NAPHTHOATE; OPTICAL RESOLUTIONS | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1990-10-30 | — | — | US | disclosed |
| US-4879038-A | Separation agent comprising acyl- or carbamoyl-substituted polysaccharide | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 1989-11-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12281104-B2 | Process for the production of ethyl 3-amino-1-[(3R,4S)-4-cyanotetrahydropyran-3-yl]pyrazole-4-carboxylate through chiral separation of a racemic mixture | CYP3A4, CYP4B1, ACMSD | ALDH1A1 457/4885CES2 574/4885CES1 159/4885 |
| US-20120087891-A1 | Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances | PGF, CEL, F12 | ALDH1A1 2015/4885CES2 480/4885CES1 543/4885 |
| US-20220204483-A1 | Process for the Production of Ethyl 3-Amino-1-[(3R,4S)-4-Cyanotetrahydropyran-3-YL]pyrazole-4-Carboxylate Through Chiral Separation of a Racemic Mixture | CYP3A4, CYP4B1, ACMSD | ALDH1A1 457/4885CES2 574/4885CES1 159/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.